[Update on Current Care Guideline: Parkinson's disease]. / Parkinsonin tauti.
Duodecim
; 132(1): 91-3, 2016.
Article
em Fi
| MEDLINE
| ID: mdl-27044185
The treatment of Parkinson's disease may be initiated with dopamine agonist or MAO-B-inhibitor for people under 60-65 years of age. For older patients, the treatment may also be started with levodopa. If there are motor complications, such as on-off-symptoms, apomorphin injections can be beneficial in addition to other medications. In the case of difficult on-off-symptoms and dyskinesias in spite of optimal treatment, deep brain stimulation, duodenal levodopa infusion and apomorphine infusion should be considered. Rehabilitation can improve gait speed and balance, decrease falls and improve speech. However, with advancing disease the results are not maintained if trainino is discontinued.
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Doença de Parkinson
/
Guias de Prática Clínica como Assunto
Tipo de estudo:
Guideline
Limite:
Aged
/
Humans
/
Middle aged
Idioma:
Fi
Ano de publicação:
2016
Tipo de documento:
Article